The median cervical muscle ROM increased from a baseline of 25% to 75% following treatment (P=0.001; WSR), while muscle tone changed from hypertonic at baseline to normal tone (P=0.0002; WSR).
With highly significant reductions in pain and impact of FM on quality of life, it is important to observe the return of FM symptoms following the end of treatment. Table 6 presents results of symptom recurrence. Although three patients (15.8%) reported no recurrence of symptoms within 14 days, 84.2% experienced a recurrence of pain (68.4%) or sleep disturbance (17.8%). For patients with recurring pain, the pain recurred within a mean of eight days (minimum seven days, maximum 14 days). For patients with recurring insomnia, the symptom recurred within a mean of 10 days (minimum seven days, maximum 14 days).